Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf Twice A Day in Adult De Novo Kidney Transplant Patients - Full Text View - ClinicalTrials.govThe purpose of this study is to demonstrate the pharmacokinetics (PK, measuring the amount of medication in blood samples) and safety of a new medicine, LCP-Tacro tablets, and Prograf capsules, a drug commonly taken by transplant recipients to prevent the body from rejecting a transplanted kidney.
